Evidence map›Paper›PMID 36950442›Full record

ArticlePakistan journal of medical sciences

COVID-19 vaccine acceptance and its drivers among Pakistani population.

Khalid Rehman, Nauman Arif, Muhammad Jawad, Ali Muhammad

Full text read
In one paragraph

Article in Pakistan journal of medical sciences. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Khalid RehmanKhalid Rehman, PhD, MPH, MBBS, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.
Nauman ArifNauman Arif, Pharm-D, MSc, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.
Muhammad JawadMuhammad Jawad, MD, MCPS, MPH, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.
Ali MuhammadAli Muhammad, BS, MPH, Institute of Public Health & Social Sciences, Khyber Medical University, Peshawar, Pakistan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Objective: COVID-19 vaccine has become available within a record time but mere availability will not control the pandemic. High vaccine acceptance is required. The objective was to determine COVID-19 vaccine acceptance and its associated factors among Pakistani population. Methods: An online survey using google form, was conducted from January 31 Result: A total of 1156 responses were received. 65% were male and 35% female. Only 6% were uneducated. Thirty percent had tested positive for COVID-19 earlier. Forty-six percent of the respondents would take (acceptance) a vaccine if available. Forty-eight percent and 45% were confident in using USA/UK and Chinese vaccine respectively. Gender and marital status was statistically significantly associated with vaccine acceptance. Concerns about the side effects were 55% while for efficacy it was 69%. Twenty-three percent were concerned about the permissibility of the vaccine on religious grounds. Conclusion: Gender and marital status was significantly associated with vaccine acceptance. Forty-six percent respondents were willing to take the vaccine. Among the vaccine hesitant group, respondents were worried about the side effects, safety and religious permissibility of vaccine. Policy makers and all the relevant stakeholders should consider low vaccine acceptance as a major bottleneck and should devise strategies to address this major issue in the fight against COVID-19.

Indexed as

AcceptanceCOVID-19HesitancyVaccination

Identifiers

PMID36950442
PMCPMC10025727

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read410
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.